Is Lack of Response to Single-Agent Chemotherapy in Gestational Trophoblastic Disease Associated with Dose Scheduling or Chemotherapy Resistance?

By Kohorn E.I.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 36-39

Elsevier

Access to resources Recommend Favorite

Volume 86, Number 1 (2002), in the article “Long-Term Survival and Patterns of Care in Women with Ovarian Tumors of Low Malignant Potential,” by Cornelia Liu Trimble, Carol Kosary, and Edward L. Trimble, pages 34–37 (doi:10.1006/gyno.2002.6711)

By  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 235-235

Academic Press

Access to resources Recommend Favorite

Volume 84, Number 3 (2002), in Abstracts Presented for the Thirty-Third Annual Meeting of the Society of Gynecologic Oncologists, pages 479–536 (doi:10.1006/gyno.2001.6565)

By  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 393-393

Academic Press

Access to resources Recommend Favorite

Erratum - Volume 76, Number 2 (2000), in ''Abstracts Presented for the Thirty-First Annual Meeting of the Society of Gynecologic Oncologists,'' pages 230-284 (doi:10.1006/gyno.1999.5695)

By  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 222-222

Elsevier

Access to resources Recommend Favorite

Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management

By Markman Maurie  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 7, 2004-07 ,pp. : 383-387

Springer Publishing Company

Access to resources Recommend Favorite